Second generation antidepressants: The pharmacological and clinical significance of selected examples
- 1 January 1983
- journal article
- review article
- Published by Wiley in Drug Development Research
- Vol. 3 (3) , 203-211
- https://doi.org/10.1002/ddr.430030302
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- BW234U,(cis-9-[3–(3,5-dimethyl-1-piperazinyl)propyl]carbazole dihydrochloride): a novel antipsychotic agentJournal of Pharmacy and Pharmacology, 1982
- Role of beta-adrenergic receptors in the mechanism of action of second-generation antidepressantsDrug Development Research, 1982
- Some neurochemical properties of a new antidepressant, bupropion hydrochloride (Wellbutrin™)Drug Development Research, 1981
- Maprotiline, nomifensine, mianserin, zimelidine: A review of antidepressant efficacy in in-patientsNeuropharmacology, 1980
- Bupropion hydrochloride ((±) α-t-butylamino-3-chloropropiophenone HCl): a novel antidepressant agentJournal of Pharmacy and Pharmacology, 1977
- Iprindole and Imipramine in Non-Psychotic Depressed Out-PatientsThe British Journal of Psychiatry, 1973
- A comparison of the inhibitory activities of iprindole and imipramine on the uptake of 5-hydroxytryptamine and noradrenaline in brain slicesLife Sciences, 1971
- Iprindole in Neurotic Depressed General Practice Patients: A Controlled StudyPsychosomatics, 1968
- Treatment of Depressed Patients With IprindolePsychosomatics, 1967
- Biogenic Amines and EmotionScience, 1967